AKI biomarkers such as Neutrophil Gelatinase- Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Cystatin C and Interleukin 18 (IL18), which are more sensitive than sCr, have been developed within the last decade [4,5]. This evidence concerns the gene LCN2 and acute kidney injury.